MedCity News

Jet trail creating dollar sign in blue sky with clouds startup capital

Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic

2026 Star Ratings Shift: 4 Strategies for MA Plans

Further change in the Star Ratings program is inevitable, but one thing won’t change: plans that make targeted investments in improving the member experience and clinical outcomes, driven by data, are the most likely to succeed and achieve a higher overall rating.

By Marge Ciancetta

Top-Rated Gel Packs for Physical Therapy: Best Brands and Where to Buy

Cold and heat therapy remain foundational tools in musculoskeletal care, postoperative recovery and sports rehabilitation.

By Pelton Shepherd

MedCity Influencers

How AI Is Transforming Detection of Congenital Heart Defects

In prenatal cardiology, that clarity can mean earlier diagnoses, safer deliveries, and better supported families who are prepared for what lies ahead.

By Dr. Nathan S. Fox

Latest Video

Latest News

Legal

DOJ, Ohio File Antitrust Suit Against OhioHealth Over Payer Contracts

The Department of Justice and the state of Ohio filed an antitrust lawsuit against OhioHealth this week, alleging the health system used “all-or-nothing” contracts that force insurers to include all of its hospitals and physicians. The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers, patients and healthcare markets across the country.

By Katie Adams

Health Tech

Care.com and Headspace Launch Mental Health Partnership for Caregivers

Headspace and Care.com partnered to provide caregivers with brief mindfulness content and free subscriptions to support their mental health.

By Marissa Plescia

BioPharma, Pharma

Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal

Gilead Sciences and Arcellx have been collaborating on the multiple myeloma cell therapy anito-cel since 2022. This therapy was designed to provide better safety, which would be an advantage over Carvykti, the blockbuster multiple myeloma product marketed by Johnson & Johnson and Legend Biotech.

By Frank Vinluan

MedCity Influencers

Prior Authorization Is Broken. CMS’s New Rule Shows Why Regulated AI Is the Way Out

Technology alone won’t solve prior authorization. But refusing to adopt it guarantees the status quo: a system where insurers operate at machine speed, providers operate at human speed, and patients pay the price in delayed care.

By Jeffrey Morelli

The Power of One: Redefining Healthcare with an AI-Driven Unified Platform

In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.

By David Cohen, Chief Product & Technology Officer, Greenway Health

MedCity Influencers

Why HealthTech Products Fail Clinical Deployment & How To Prevent It

Companies can avoid this trap by treating future growth as a foundation, not a later stage. Decision makers need to work backwards from scale, building software architecture and commercial architecture together. This shift alone helps teams make smarter choices within the first 90 days of a product’s launch.

By Sanket Patel

Health Tech, Hospitals, Providers

The Rural Care Crisis Is an Economic Issue, Not Just a Public Health One

As hundreds of rural hospitals face the risk of closure, healthcare leaders warn that the fallout extends far beyond patient outcomes. During a panel at ViVE in Los Angeles, healthcare leaders outlined how access to care underpins the economic stability of rural America.

By Katie Adams

Health Tech

What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus

Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges.

By Marissa Plescia

MedCity Influencers

Why Providers Can’t Ignore CMS Audits

At the end of the day, it doesn’t matter what your patient mix looks like; your notes can and will be pulled into audits. Waiting until CMS is at your doorstep isn’t a strategy — it’s a risk. Now is the moment to get ahead of it.

By Farshid Kazi

BioPharma, Startups

Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug

Korsana Biosciences’ preclinical Alzheimer’s disease drug comes from a platform technology that enables antibodies to cross the blood-brain barrier. Roche and AbbVie have clinical-stage drugs taking a similar approach to Alzheimer’s.

By Frank Vinluan

BioPharma

MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated?

Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance

By Arundhati Parmar

MedCity Influencers

AI is Changing Nursing Education and Raising New Graduate Expectations

Early experience and comfort with AI benefits everyone. Nurses who understand how to work alongside technology are better equipped to deliver high-quality care, adapt to new systems, and navigate increasingly complex clinical environments.

By Christine “Christy” Heid

Artificial Intelligence, Startups, Health Tech, Providers

Green upward arrow pointing to a blue dollar sign on a pink background representing increasing profits, financial success, and economic growth

How Arintra’s Coding AI Helped Mercyhealth Boost Revenue by 5%

Since adopting Arintra’s AI platform for medical coding in 2023, Mercyhealth has seen a 5.1% rise in revenue and a 50% decline in its days in accounts receivable. The AI-powered platform automates coding, spots documentation gaps and generates claims tailored to specific payers.

By Katie Adams

Diagnostics, BioPharma

Grail’s Galleri Blood Test Falls Short in Large Cancer-Screening Study, Shares Sink 50%

Despite missing statistical significance, Grail said the observation of trending improvement suggests potential for better results with more time, so the company is extending follow up by up to a year. More detailed trial results will be submitted for presentation at the annual meeting of the American Society of Clinical Oncology.

By Frank Vinluan

Health Tech, Providers

Rainfall Health Raises $15M to Help Hospitals Navigate New CMS Model

Rainfall Health's Series A round was led by Two Bear Capital. In total, the startup has raised $18 million.

By Marissa Plescia